GNE-375

CAS No. 1926989-06-1

GNE-375( GNE375 )

Catalog No. M13018 CAS No. 1926989-06-1

GNE-375 is a potent, selective BRD9 inhibitor with IC50 of 5 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 315 In Stock
5MG 278 In Stock
10MG 432 In Stock
25MG 708 In Stock
50MG 995 In Stock
100MG 1460 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GNE-375
  • Note
    Research use only, not for human use.
  • Brief Description
    GNE-375 is a potent, selective BRD9 inhibitor with IC50 of 5 nM.
  • Description
    GNE-375 is a potent, selective BRD9 inhibitor with IC50 of 5 nM, displays >480-fold selectivity over BRD4, CECR2, and TAF1; decreases BRD9 binding to chromatin, and decreases expression of ALDH1A1, a gene previously shown to be important in drug tolerance; shows remarkable potency in preventing the emergence of a drug tolerant population in EGFR mutant PC9 cells treated with EGFR inhibitors.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    GNE375
  • Pathway
    Chromatin/Epigenetic
  • Target
    Bromodomain
  • Recptor
    Bromodomain
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1926989-06-1
  • Formula Weight
    451.523
  • Molecular Formula
    C25H29N3O5
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (110.74 mM)
  • SMILES
    O=C1C(NC=C2)=C2C(C3=CC(OC)=C(C(N4CCOCC4)=O)C=C3OC)=CN1C/C=C/C
  • Chemical Name
    (E)-6-(but-2-en-1-yl)-4-(2,5-dimethoxy-4-(morpholine-4-carbonyl)phenyl)-2-methyl-1,6-dihydro-7H-pyrrolo[2,3-c]pyridin-7-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Crawford TD, et al. Bioorg Med Chem Lett. 2017 Aug 1;27(15):3534-3541.
molnova catalog
related products
  • I-BET762

    I-BET762 (GSK-525762A, Molibresib) is a highly potent, selective inhibitor of BET family proteins.

  • INCB054329

    INCB054329 is a novel potent, orally bioactive BET inhibitor that inhibits binding of BRD2, BRD3 and BRD4 to an acetylated histone H4 peptide with low nanomolar potency.

  • ZL0420

    ZL0420 is a potent, highly selective BRD4 inhibitor with IC50 of 27 and 32 nM for BRD4-BD1 and BRD4-BD2, respectively.